In addition, the patients involved in the present study were divided into three groups (1): TFE3-negative RCC group (2), Xp11.2 translocation RCC group, and (3) TFE3-positive non-Xp11.2 translocation RCC group. Here, TFE3 is linked to renal cell carcinoma.